newsfilter
← Latest News
GlobeNewswire·

Ambrx to Present Preclinical Data on ARX517 and ARX305 at the 2023 AACR Annual Meeting

SAN DIEGO, March 27, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ:AMAM), announced the presentation of three posters featuring preclinical data at the upcoming 2023 American Association for Cancer